MPD: List measures where strain BALB/cJ is an outlier

List measures where BALB/cJ is an outlier

Click on pulldowns below to see BALB/cJ means with summary statistic tooltips.
Within each pulldown, the "up" and "down" triangles indicate when this strain is an outlier.
You can also download all phenotypes for this strain and sort by Z score in Excel.

Sort/ Pick	Data set	Procedure / Protocol	Treatment	Phenotype Measure / Variable (click to view)	Panel	No. of Strains	Sex	Age	Sample Size (Avg)	Year
Berndt2:1	Berndt2	plethysmography	methacholine	minute ventilation [mL/min] min_vent 35101 saline 5 MCh 10 MCh 20 MCh response index	inbred	29	both	9-12wks	N=8	2010

Berndt2:8	Berndt2	plethysmography	methacholine	breath frequency [n/min] breath_freq 35108 saline 5 MCh 10 MCh 20 MCh response index	inbred	29	both	9-12wks	N=8	2010

Berndt2:41	Berndt2	plethysmography	methacholine	inspiratory flow rate [mL/kg/s] insp_flow 35141 saline 5 MCh 10 MCh 20 MCh response index	inbred	29	both	9-12wks	N=8	2010

Berndt2:48	Berndt2	plethysmography	methacholine	expiratory flow rate [mL/kg/s] exp_flow 35148 saline 5 MCh 10 MCh 20 MCh response index	inbred	29	both	9-12wks	N=8	2010

Berndt2:54	Berndt2	plethysmography	methacholine	respiratory flow rate [mL/kg/s] resp_flow 35154 saline 5 MCh 10 MCh 20 MCh response index	inbred	29	both	9-12wks	N=8	2010

Berndt2:68	Berndt2	plethysmography	methacholine	tidal volume [mL] tidal_vol 35168 saline 5 MCh 10 MCh 20 MCh response index	inbred	29	both	9-12wks	N=8	2010

Bodnar1:1	Bodnar1	intake monitoring	sucrose	daily chow intake with sucrose in drinking water [g] chow 22601 baseline 0.01% 2.5% 20%	inbred	11	m	13-17wks	N=10	2006

Bodnar1:9	Bodnar1	intake monitoring	sucrose	total daily caloric intake with sucrose in drinking water [kcal] total_kcal 22609 baseline 0.01% 2.5% 20%	inbred	11	m	13-17wks	N=10	2006

Bodnar1:13	Bodnar1	intake monitoring	sucrose	daily chow caloric intake with sucrose in drinking water [kcal] chow_kcal 22613 baseline 0.01% 2.5% 20%	inbred	11	m	13-17wks	N=10	2006

Boon1:11	Boon1	body weight	influenza A (H5N1) virus	change in body weight, post-infection [%] bw_change 46911 dosage group: low medium high	inbred	23	f	6-9wks	N=11	2011

Boon1:21	Boon1	health assessment	influenza A (H5N1) virus	survival (days to death, max 30) [d] survival 46921 dosage group: low medium high	inbred	23	f	6-9wks	N=11	2011

Boon1:31	Boon1	health assessment	influenza A (H5N1) virus	susceptibility to viral infection (0=susceptible, 1=resistant) [designation] resistance 46931 dosage group: low medium high	inbred	23	f	6-9wks	N=11	2011

Brown1:10	Brown1	open field test	(none)	fecal boli count, 5 min test, day 1 [n] defecation_d1_OFT 9410	inbred	14	both	10wks	N=13	2004

Brown2:56	Brown2	visual water box	(none)	visual discrimination, pattern discrimination mean latency to reach cued platform, day 8 [s] pat_disc_ave_d8 22556	inbred	14	both	10-18wks	N=7	2004

Brown2:57	Brown2	visual water box	(none)	latency to reach cued platform [s] vis_acuit 22557 grating threshold: 0.17 (low) 0.32 0.64 (high) overall mean	inbred	14	both	10-18wks	N=7	2004

Hampton1:4	Hampton1	ECG	(none)	heart rate [n/min] HR 1704	inbred	17	both	9-12wks	N=8	2001

Hampton1:5	Hampton1	ECG	(none)	heart rate variability [n/min] HR_VAR 1705	inbred	17	both	9-12wks	N=8	2001

Hampton1:6	Hampton1	ECG	(none)	interval between R-waves (RR) [ms] RR 1706	inbred	17	both	9-12wks	N=8	2001

Hampton1:9	Hampton1	ECG	(none)	interval between beginning and end of QRS complex [ms] QRS 1709	inbred	17	both	9-12wks	N=8	2001

Harrill1:41	Harrill1	histopathology	isoniazid	lymphohistiocytic, portal, multifocal infiltrate [score] lymphohistio_portal 39541 control isoniazid	inbred	34	f	8-10wks	N=4	2011

Harrill1:46	Harrill1	histopathology	isoniazid	hepatocytic cytoplasmic, microvesiculation, multifocal [score] microvesic_multi 39546 control isoniazid	inbred	34	f	8-10wks	N=4	2011

Harrill1:51	Harrill1	histopathology	isoniazid	hepatocytic cytoplasmic, microvesiculation, diffuse [score] microvesic_dif 39551 control isoniazid	inbred	34	f	8-10wks	N=4	2011

HMDPpheno4:1	HMDPpheno4	fear conditioning test	(none)	fear training, percent time spent near chamber walls, day1 [%] ftr_thig 46801 pre-stimulus post-stimulus	HMDP w/par	94	m	10wks	N=7	2011

HMDPpheno4:31	HMDPpheno4	fear conditioning test	(none)	fear training activity burst to footshock, shock reactivity, day 1 [cm/s] ftr_post_act_burst 46831	HMDP w/par	94	m	10wks	N=7	2011

HMDPpheno4:36	HMDPpheno4	fear conditioning test	(none)	contextual fear thigmotaxis, percent time spent near chamber walls, day 2 [%] ctx_thig 46836	HMDP w/par	94	m	10wks	N=7	2011

HMDPpheno8:5	HMDPpheno8	metabolite quantification	(none)	12-dehydrocholate (16h fast), relative abundance dehydrocholate 50305	HMDP	106	m	16wks	N=1	2014

HMDPpheno8:6	HMDPpheno8	metabolite quantification	(none)	6-beta-hydroxylithocholate (16h fast), relative abundance hydroxylithocholate 50306	HMDP	106	m	16wks	N=1	2014

HMDPpheno8:8	HMDPpheno8	metabolite quantification	(none)	taurocholate (16h fast), relative abundance taurocholate 50308	HMDP	106	m	16wks	N=1	2014

HMDPpheno8:10	HMDPpheno8	metabolite quantification	(none)	ursodeoxycholate (16h fast), relative abundance ursodeoxycholate 50310	HMDP	106	m	16wks	N=1	2014

HMDPpheno8:35	HMDPpheno8	metabolite quantification	(none)	undecanedioate (16h fast), relative abundance undecanedioate 50335	HMDP	105	m	16wks	N=1	2014

HMDPpheno8:83	HMDPpheno8	metabolite quantification	(none)	liver stearoyl sphingomyelin (16h fast), relative abundance SO_sphingomyelin 50383	HMDP	96	m	16wks	N=1	2014

HMDPpheno8:88	HMDPpheno8	metabolite quantification	(none)	liver vsqualene (16h fast), relative abundance squalene 50388	HMDP	93	m	16wks	N=1	2014

Jaxpheno2:10	Jaxpheno2	organ weights	(none)	heart weight [g] heart 22710 age 8wks age 16wks	inbred	11	both		N=8	2006

Jaxpheno2:12	Jaxpheno2	organ weights	(none)	heart weight as percentage of body weight [%] pct_heart 22712 age 8wks age 16wks	inbred	11	both		N=8	2006

Jaxpheno3:50	Jaxpheno3	metabolic panel	(none)	calcium (plasma Ca) [mg/dL] Ca 22850 age 8wks age 16wks	inbred	11	both		N=16	2006

Jaxpheno4:38	Jaxpheno4	complete blood count	(none)	basophil differential (BASO; percentage of total WBC) [%] pct_BASO 22938 age 8wks age 16wks	inbred	11	both		N=17	2006

Kumar4:7	Kumar4	gait analysis	(none)	angular velocity over duration of stride, variance [deg/s] angular_velocity_var 114437	inbred w/CC8	62	both	10-20wks	N=19	2021

Kumar4:23	Kumar4	gait analysis	(none)	distance left hind paw keypoint travels past the right hind paw keypoint strike, mean [cm] step_length2_mean 114453	inbred w/CC8	62	both	10-20wks	N=19	2021

Kumar4:24	Kumar4	gait analysis	(none)	distance left hind paw keypoint travels past the right hind paw keypoint strike, median [cm] step_length2_median 114454	inbred w/CC8	62	both	10-20wks	N=19	2021

Kumar4:29	Kumar4	gait analysis	(none)	distance left hind paw keypoint travels for a stride, from toe-off to foot-strike, mean [cm] stride_length_mean 114459	inbred w/CC8	62	both	10-20wks	N=19	2021

Lightfoot1:80	Lightfoot1	colony observation	(none)	age at testing (local parameter) [d] age 35780	inbred	41	both		N=6	2010

Mitchell1:6	Mitchell1	go/no-go task	(none)	latency to respond to Go cue [s] go_latency 37606	inbred	15	m	5-7wks	N=8	2010

Mogil1:24	Mogil1	nociception assay	(none)	latency of tail withdrawal, -15°C cold stimulation [s] TW_COLD 2224	inbred	12	m	6-18wks	N=5	2002

Mogil1:28	Mogil1	nociception assay	(none)	latency of nociception to pinched tail [s] TC 2228	inbred	12	m	6-18wks	N=7	2002

Paigen1:11	Paigen1	histopathology	high-fat diet	gallbladder, filaments (score: 0-4) [score] filaments 2911	inbred	43	both	15-19wks	N=8	2000

Peters1:7	Peters1	complete blood count	(none)	mean RBC corpuscular hemoglobin concentration (MCHC) [g/dL] MCHC 6207	inbred w/CC7	43	both	10wks	N=12	2001

Peters1:10	Peters1	complete blood count	(none)	hemoglobin concentration distribution width (HDW) [g/dL] HDW 6210	inbred w/CC7	43	both	10wks	N=12	2001

Peters1:17	Peters1	complete blood count	(none)	reticulocyte differential (percent of total RBC) [%] Retic 6217	inbred w/CC7	43	both	10wks	N=12	2001

Peters1:20	Peters1	complete blood count	(none)	mean platelet volume (MPV) [fL] MPV 6220	inbred w/CC7	43	both	10wks	N=12	2001

Schwartz2:1	Schwartz2	bronchoalveolar lavage assessment	ovalbumin	alveolar eosinophils (percentage of total lavage cells), pre-challenge [%] pctEOS0 9801 pre-test: control OVA-sensitized	inbred	8	m	6-8wks	N=3	2001

Schwartz2:22	Schwartz2	bronchoalveolar lavage assessment	ovalbumin	alveolar lymphocytes (percentage of total lavage cells), 24h post-challenge [%] pctLYM24 9822 24h post: control OVA-sensitized	inbred	8	m	6-8wks	N=5	2001

Thomsen2:1	Thomsen2	open field test	R-6-Br-APB	total activity, dose response to D1 agonist, 3h test [n] activ_D1 40801 baseline dose mg/kg i.p. 0.03 0.32 3.2 5.6	inbred	15	both	8-10wks	N=8	2011

Thomsen2:6	Thomsen2	open field test	quinelorane	total activity, dose response to D2 agonist, 3h test [n] activ_D2 40806 baseline dose mg/kg i.p. 0.03 0.32 3.2 5.6	inbred	15	both	8-10wks	N=8	2011

Willott1:2	Willott1	acoustic startle test	(none)	acoustic startle response (ASR) [amplitude] ASR 9102 sound pressure level: 70dB 80dB 90dB 100dB	inbred w/CC7	40	both	5-6wks	N=10	2002

Zheng1:3	Zheng1	tympanometry	(none)	middle ear gradient at maximum compliance, right ear [mL] Rgradient 29803	inbred	61	both	5-68wks	N=4	2008

Zheng1:4	Zheng1	tympanometry	(none)	middle ear pressure at maximum compliance, right ear [daPa] Rpressure 29804	inbred	61	both	5-68wks	N=4	2008

Zimmermann1:9	Zimmermann1	monitoring system	(none)	fine or stationary movement on x-y axis, repeated interruptions of same beam, second day (beam breaks/min) [n/min] fine_act 112172 during light during dark	inbred	30	both	7-15wks	N=11	2020

Zimmermann1:13	Zimmermann1	monitoring system	(none)	rearing movement, number of z-axis beam breaks, second day (beam breaks/min) [n/min] rearing_act 112176 during light during dark	inbred	30	both	7-15wks	N=11	2020

List measures where BALB/cJ is an outlier

Filter Table Results